Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
Crossref DOI link: https://doi.org/10.1007/s10792-017-0512-8
Published Online: 2017-04-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Konidaris, Vasileios
Al-Hubeshy, Zahra
Tsaousis, Konstantinos T.
Gorgoli, Konstantina
Banerjee, Somnath
Empeslidis, Theodoros
License valid from 2017-04-12